aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Abilita Bio, founded with a mission to unlock the full therapeutic potential of membrane protein targets, focuses on the discovery and development of drugs targeting G Protein Coupled Receptors (GPCRs) and ion channels. The company leverages its proprietary EMP™ technology to address medically important targets that are often deemed 'intractable' or 'undruggable.' By enabling the use of purified proteins in drug discovery processes, Abilita Bio aims to create transformative treatment options for future patients.
Key figures affiliated with Abilita Bio include experts in biotechnology and drug discovery, though specific names are not provided. The company has garnered attention for its innovative approach and has likely attracted investment from venture capital firms specializing in biotech. Abilita Bio's impact lies in its potential to revolutionize the druggable landscape, offering new avenues for treating diseases that currently lack effective therapies.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Drug Discovery
Technology
Biotech
Tags
Biotech, API
Model Types
Licensing, Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Abilita Bio founded?
Abilita Bio was founded in 2014.
Where is Abilita Bio’s headquarters located?
Abilita Bio’s headquarters is located in San Diego, CA, US.
When was Abilita Bio’s last funding round?
Abilita Bio’s most recent funding round was for $7.5M (USD) in February 2023.
How many employees does Abilita Bio have?
Abilita Bio has 14 employees as of Feb 5, 2024.
How much has Abilita Bio raised to-date?
As of July 05, 2023, Abilita Bio has raised a total of $7.5M (USD) since Feb 21, 2023.
Add Comparison
Total Raised to Date
$7.5M
USD
Last Update Feb 21, 2023
Last Deal Details
$7.5M
USD
Feb 21, 2023
Series Unknown
Total Employees Over Time
14
As of Feb 2024
Abilita Bio Address
3210 Merryfield Row
San Diego,
California
92121-1126
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts